Literature DB >> 23671826

Neuroprotective effects of carnosic Acid in an experimental model of Alzheimer's disease in rats.

Nahid Azad1, Homa Rasoolijazi, Mohammad Taghi Joghataie, Sara Soleimani.   

Abstract

OBJECTIVE: Alzheimer's disease is the most common type of neurodegenerative disorder. It has been suggested that oxidative stress can be one of the pathological mechanisms of this disease. Carnosic acid (CA) is an effective antioxidant substance and recent studies have shown that its electrophilic compounds play a role in reversing oxidative stress. Thus we tried to find out whether CA administration protects hippocampal neurons, preventing neurodegeneration in rats.
MATERIALS AND METHODS: ANIMALS WERE DIVIDED INTO FOUR GROUPS: Sham-operated (sham), CA-pretreated sham-operated (sham+CA), untreated lesion (lesion) and CA-pretreated lesion (lesion+CA). Animals in all groups received vehicle or vehicle plus CA (CA: 10mg/ kg) intra-peritoneally one hour before surgery, again the same solution injected 3-4 hours after surgery (CA: 3 mg/kg) and repeated each afternoon for 12 days. A lesion was made by bilateral intra-hippocampal injection of 4 µl of beta amyloid protein (1.5 nmol/µl) or vehicle in each side. 14 days after surgery, the brains were extracted for histochemical studies. Data was expressed as mean ± SEM and analyzed using SPSS statistical software.
RESULTS: Results showed that pretreatment with carnosic acid can reduce cellular death in the cornu ammonis 1 (CA1) region of the hippocampus in the lesion+CA group, as compared with the lesion group.
CONCLUSION: Carnosic acid may be useful in protecting against beta amyloid-induced neurodegeneration in the hippocampus.

Entities:  

Keywords:  Alzheimer’s Disease; Carnosic Acid, ,; Hippocampus

Year:  2011        PMID: 23671826      PMCID: PMC3652539     

Source DB:  PubMed          Journal:  Cell J        ISSN: 2228-5806            Impact factor:   2.479


  17 in total

Review 1.  Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.

Authors:  L Giménez-Llort; G Blázquez; T Cañete; B Johansson; S Oddo; A Tobeña; F M LaFerla; A Fernández-Teruel
Journal:  Neurosci Biobehav Rev       Date:  2006-10-20       Impact factor: 8.989

2.  Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1.

Authors:  Takumi Satoh; Kunio Kosaka; Ken Itoh; Akira Kobayashi; Masayuki Yamamoto; Yosuke Shimojo; Chieko Kitajima; Jiankun Cui; Joshua Kamins; Shu-ichi Okamoto; Masanori Izumi; Takuji Shirasawa; Stuart A Lipton
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

Review 3.  Antioxidant treatment in Alzheimer's disease: current state.

Authors:  Yossi Gilgun-Sherki; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

4.  Chemiluminescence determination of the in vivo and in vitro antioxidant activity of RoseOx and carnosic acid.

Authors:  A I Kuzmenko; R P Morozova; I A Nikolenko; G V Donchenko; S L Richheimer; D T Bailey
Journal:  J Photochem Photobiol B       Date:  1999-01       Impact factor: 6.252

5.  Carnosic acid, a new class of lipid absorption inhibitor from sage.

Authors:  Kiyofumi Ninomiya; Hisashi Matsuda; Hiroshi Shimoda; Norihisa Nishida; Naoki Kasajima; Tomoe Yoshino; Toshio Morikawa; Masayuki Yoshikawa
Journal:  Bioorg Med Chem Lett       Date:  2004-04-19       Impact factor: 2.823

6.  Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid.

Authors:  O I Aruoma; B Halliwell; R Aeschbach; J Löligers
Journal:  Xenobiotica       Date:  1992-02       Impact factor: 1.908

7.  Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes.

Authors:  Daniel Poeckel; Christine Greiner; Moritz Verhoff; Oliver Rau; Lars Tausch; Christina Hörnig; Dieter Steinhilber; Manfred Schubert-Zsilavecz; Oliver Werz
Journal:  Biochem Pharmacol       Date:  2008-05-01       Impact factor: 5.858

Review 8.  Angiotensins in Alzheimer's disease - friend or foe?

Authors:  Patrick G Kehoe; Scott Miners; Seth Love
Journal:  Trends Neurosci       Date:  2009-09-30       Impact factor: 13.837

9.  Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.

Authors:  Todd E Golde; Victor M Miller
Journal:  Alzheimers Res Ther       Date:  2009-10-12       Impact factor: 6.982

Review 10.  Alzheimer disease models and human neuropathology: similarities and differences.

Authors:  Charles Duyckaerts; Marie-Claude Potier; Benoît Delatour
Journal:  Acta Neuropathol       Date:  2007-11-16       Impact factor: 17.088

View more
  22 in total

1.  Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.

Authors:  Nurit Hadad; Rachel Levy
Journal:  Neuromolecular Med       Date:  2017-08-04       Impact factor: 3.843

2.  Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.

Authors:  J Rodriguez-Blanco; L Pednekar; C Penas; B Li; V Martin; J Long; E Lee; W A Weiss; C Rodriguez; N Mehrdad; D M Nguyen; N G Ayad; P Rai; A J Capobianco; D J Robbins
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

3.  Carnosic acid alleviates depression-like behaviors on chronic mild stressed mice via PPAR-γ-dependent regulation of ADPN/FGF9 pathway.

Authors:  Xiao-Qing Wang; Ya-Hui Tang; Gui-Rong Zeng; Li-Feng Wu; Ying-Jun Zhou; Ze-Neng Cheng; De-Jian Jiang
Journal:  Psychopharmacology (Berl)       Date:  2020-11-07       Impact factor: 4.530

4.  Carnosic Acid Prevents Beta-Amyloid-Induced Injury in Human Neuroblastoma SH-SY5Y Cells via the Induction of Autophagy.

Authors:  Jie Liu; Hua Su; Qiu-Min Qu
Journal:  Neurochem Res       Date:  2016-05-11       Impact factor: 3.996

5.  Carnosic Acid Affords Mitochondrial Protection in Chlorpyrifos-Treated Sh-Sy5y Cells.

Authors:  Marcos Roberto de Oliveira; Alessandra Peres; Gustavo Costa Ferreira; Patrícia Fernanda Schuck; Simone Morelo Dal Bosco
Journal:  Neurotox Res       Date:  2016-04-15       Impact factor: 3.911

6.  5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease.

Authors:  Nasrin Hashemi-Firouzi; Siamak Shahidi; Sara Soleimani-Asl; Alireza Komaki
Journal:  Metab Brain Dis       Date:  2018-04-17       Impact factor: 3.584

Review 7.  Flavonoid-based therapies in the early management of neurodegenerative diseases.

Authors:  Isha Solanki; Priyanka Parihar; Mohammad Lukman Mansuri; Mordhwaj S Parihar
Journal:  Adv Nutr       Date:  2015-01-15       Impact factor: 8.701

Review 8.  Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation.

Authors:  Roberto Iorio; Giuseppe Celenza; Sabrina Petricca
Journal:  Antioxidants (Basel)       Date:  2022-06-18

Review 9.  Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.

Authors:  Takumi Satoh; Scott R McKercher; Stuart A Lipton
Journal:  Free Radic Biol Med       Date:  2013-07-25       Impact factor: 7.376

Review 10.  The Dietary Components Carnosic Acid and Carnosol as Neuroprotective Agents: a Mechanistic View.

Authors:  Marcos Roberto de Oliveira
Journal:  Mol Neurobiol       Date:  2015-11-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.